Entering text into the input field will update the search result below

Vanda Pharmaceuticals Inc. (VNDA) Q1 2023 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts
142.44K Followers

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2023 Earnings Conference Call May 3, 2023 4:30 AM ET

Company Participants

Kevin Moran - CFO

Mihael Polymeropoulos - President, CEO and Chairman

Timothy Williams - General Counsel

Conference Call Participants

Operator

Good afternoon. My name is David and I’ll be your conference operator today. At this time, I’d like to welcome everyone to the Q1 2023 Vanda Pharmaceuticals Inc. Earnings Conference Call. Today’s conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. [Operator Instructions]

I’d now like to turn the call over to Vanda Pharmaceutical’s Chief Financial Officer, Kevin Moran. You may begin your conference.

Kevin Moran

Thank you, David. Good afternoon, and thank you for joining us to discuss Vanda Pharmaceuticals first quarter 2023 performance. Our first quarter 2023 results were released this afternoon and are available on the SEC's EDGAR system and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.

Joining me on today's call is Dr. Mihael Polymeropoulos, our President, Chief Executive Officer and Chairman of the Board; and Tim Williams, our General Counsel. Following my introductory remarks, Mihael will update you on our ongoing activities. I will then comment on our financial results before opening the lines for your questions.

Before we proceed, I would like to remind everyone that various statements that we make on this call will be forward-looking statements within the meaning of federal securities laws. Our forward-looking statements are based upon current expectations and assumptions that involve risks, changes in circumstances and uncertainties. These risks are described in the cautionary note regarding forward-looking statements, Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operations sections of

Recommended For You

Comments (1)

I
$500 million bucks in hand, selling for $350 million. Any good win triples this stock overnight.
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About VNDA

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on VNDA

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.